176 related articles for article (PubMed ID: 35438418)
1. Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction.
Nanayakkara S; Kaye DM
Heart Fail Rev; 2023 Mar; 28(2):281-286. PubMed ID: 35438418
[TBL] [Abstract][Full Text] [Related]
2. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.
Kaye DM; Petrie MC; McKenzie S; Hasenfuβ G; Malek F; Post M; Doughty RN; Trochu JN; Gustafsson F; Lang I; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Hausleiter J; Raake P; Jondeau G; Bergmann MW; Spelman T; Aytug H; Ponikowski P; Hayward C;
ESC Heart Fail; 2019 Feb; 6(1):62-69. PubMed ID: 30311437
[TBL] [Abstract][Full Text] [Related]
3. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.
Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Walton A; Muller D; Walters D; Hausleiter J; Raake P; Petrie MC; Bergmann M; Jondeau G; Feldman T; Veldhuisen DJ; Ponikowski P; Silvestry FE; Burkhoff D; Hayward C
Circ Heart Fail; 2016 Dec; 9(12):e003662. PubMed ID: 27852653
[TBL] [Abstract][Full Text] [Related]
4. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.
De Rosa R; Schranz D
Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205
[TBL] [Abstract][Full Text] [Related]
5. Interatrial Shunt Devices.
Salah HM; Baratto C; Yaranov DM; Rommel KP; Achanta S; Caravita S; Reddy Vasanthu VK; Fudim M
Heart Fail Clin; 2024 Jan; 20(1):61-69. PubMed ID: 37953022
[TBL] [Abstract][Full Text] [Related]
6. [InterAtrial Shunt Device in diastolic heart failure].
Hasenfuß G; Jacobshagen C
Internist (Berl); 2018 Oct; 59(10):1054-1062. PubMed ID: 30194481
[TBL] [Abstract][Full Text] [Related]
7. Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction.
Riccardi M; Tomasoni D; Vizzardi E; Metra M; Adamo M
Heart Fail Rev; 2023 Mar; 28(2):315-330. PubMed ID: 36402928
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
[TBL] [Abstract][Full Text] [Related]
10. Update on Devices for Diastolic Dysfunction: Options for a No Option Condition?
Gupta A; Bailey SR
Curr Cardiol Rep; 2018 Aug; 20(10):85. PubMed ID: 30112586
[TBL] [Abstract][Full Text] [Related]
11. Interatrial Shunting, a Novel Device-Based Therapy for Patients With Heart Failure.
Yum BKW; Frishman WH
Cardiol Rev; 2018; 26(5):267-273. PubMed ID: 30080749
[TBL] [Abstract][Full Text] [Related]
12. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
[TBL] [Abstract][Full Text] [Related]
14. InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.
Kosowski M; Kübler P; Kołodziej A; Krakowiak B; Kustrzycka-Kratochwil D; Sławin J; Sokolski M; Biegus J; Zymliński R; Banasiak W; Ponikowski P; Reczuch K
Kardiol Pol; 2017; 75(8):736-741. PubMed ID: 28541594
[TBL] [Abstract][Full Text] [Related]
15. Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload.
van Wezenbeek J; Kianzad A; van de Bovenkamp A; Wessels J; Mouratoglou SA; Braams NJ; Jansen SMA; Meulblok E; Meijboom LJ; Marcus JT; Vonk Noordegraaf A; José Goumans M; Jan Bogaard H; Handoko ML; de Man FS
Circ Heart Fail; 2022 Feb; 15(2):e008726. PubMed ID: 34937392
[TBL] [Abstract][Full Text] [Related]
16. Device Therapy for Heart Failure with Preserved Ejection Fraction.
Salah HM; Levin AP; Fudim M
Cardiol Clin; 2022 Nov; 40(4):507-515. PubMed ID: 36210134
[TBL] [Abstract][Full Text] [Related]
17. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
Borlaug BA; Blair J; Bergmann MW; Bugger H; Burkhoff D; Bruch L; Celermajer DS; Claggett B; Cleland JGF; Cutlip DE; Dauber I; Eicher JC; Gao Q; Gorter TM; Gustafsson F; Hayward C; van der Heyden J; Hasenfuß G; Hummel SL; Kaye DM; Komtebedde J; Massaro JM; Mazurek JA; McKenzie S; Mehta SR; Petrie MC; Post MC; Nair A; Rieth A; Silvestry FE; Solomon SD; Trochu JN; Van Veldhuisen DJ; Westenfeld R; Leon MB; Shah SJ;
Circulation; 2022 May; 145(21):1592-1604. PubMed ID: 35354306
[TBL] [Abstract][Full Text] [Related]
18. Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.
Bauer A; Khalil M; Lüdemann M; Bauer J; Esmaeili A; De-Rosa R; Voelkel NF; Akintuerk H; Schranz D
Clin Res Cardiol; 2018 Sep; 107(9):845-857. PubMed ID: 29663123
[TBL] [Abstract][Full Text] [Related]
19. State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure.
Al-Sadawi M; Ortega RR; Ariyaratnam J; Battisha A; Madoukh B; Bukharovich I
Curr Cardiol Rev; 2021; 17(5):e230421189012. PubMed ID: 33305708
[TBL] [Abstract][Full Text] [Related]
20. Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure.
Griffin JM; Borlaug BA; Komtebedde J; Litwin SE; Shah SJ; Kaye DM; Hoendermis E; Hasenfuß G; Gustafsson F; Wolsk E; Uriel N; Burkhoff D
J Am Heart Assoc; 2020 Sep; 9(17):e016760. PubMed ID: 32809903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
